Tuesday, May 9, 2017

A Trivial Amendment -- To Schedules In Merck's Federal Propecia®/Proscar® MDL -- In Brooklyn, Today...


I note it primarily to keep a complete record. [Last update here, on the state cases -- and the last prior update, here -- on the federal New York (Brooklyn) MDL.]

I still believe the federal finasteride MDL will go to trial, on bellwether cases, before the New Jersey State consolidated cases (called an MCL). Here is the order, as just entered this morning:

. . . .1. The following amendment to Practice and Procedure Order No. 15 (Amended) relates only to the Expert Reports and Expert Discovery for Cases in the First Bellwether Tranche.

2. On or before June 15, 2017, Plaintiff in the Z [redacted] case will disclose in writing the identities of his experts and will serve the reports and other materials required by Fed. R. Civ. P. 26, including case-specific reports.

3. On or before July 13, 2017, Merck will disclose in writing the identities of their experts for Z [redacted] and will serve the reports and other materials required by Fed. R. Civ. P. 26, including case specific reports.

4. On or before July 25, 2017, Plaintiff in the Z [redacted] case will disclose rebuttal expert reports, if any.

5. All other dates in Amended Practice and Procedure Order No. 15, entered on February 15, 2017, remain in effect. . . .


Now you know -- onward, for a bit of a chilly walk -- shopping for Mother's Day. . . . smile.

नमस्ते

No comments: